Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[These data provide evidence that pEGFR expression is related to angiogenesis (via VEGFR-1/Flt-1, MMP-14 and pAkt pathways) and invasiveness (via uPAR, MMP-14 and pAkt pathways) and that the EGFR/pEGFR phenotype is associated with poor patient survival in invasive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP615735.RA0rywJmbFE3JNg-MtJ4venNvpfbPZQtprjlLALrO1bPY130_assertion description "[These data provide evidence that pEGFR expression is related to angiogenesis (via VEGFR-1/Flt-1, MMP-14 and pAkt pathways) and invasiveness (via uPAR, MMP-14 and pAkt pathways) and that the EGFR/pEGFR phenotype is associated with poor patient survival in invasive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615735.RA0rywJmbFE3JNg-MtJ4venNvpfbPZQtprjlLALrO1bPY130_provenance.
• assertion description "[These data provide evidence that pEGFR expression is related to angiogenesis (via VEGFR-1/Flt-1, MMP-14 and pAkt pathways) and invasiveness (via uPAR, MMP-14 and pAkt pathways) and that the EGFR/pEGFR phenotype is associated with poor patient survival in invasive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These data provide evidence that pEGFR expression is related to angiogenesis (via VEGFR-1/Flt-1, MMP-14 and pAkt pathways) and invasiveness (via uPAR, MMP-14 and pAkt pathways) and that the EGFR/pEGFR phenotype is associated with poor patient survival in invasive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These data provide evidence that pEGFR expression is related to angiogenesis (via VEGFR-1/Flt-1, MMP-14 and pAkt pathways) and invasiveness (via uPAR, MMP-14 and pAkt pathways) and that the EGFR/pEGFR phenotype is associated with poor patient survival in invasive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP674824.RACibjF4Inv478sX21XHWPNYvop0fxF-88w9pvil36OYU130_assertion description "[These data provide evidence that pEGFR expression is related to angiogenesis (via VEGFR-1/Flt-1, MMP-14 and pAkt pathways) and invasiveness (via uPAR, MMP-14 and pAkt pathways) and that the EGFR/pEGFR phenotype is associated with poor patient survival in invasive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP674824.RACibjF4Inv478sX21XHWPNYvop0fxF-88w9pvil36OYU130_provenance.
• NP566413.RAPv7IUCcEE0H9LuU2HC04amGNdtKWkLwtWMK4waykx0w130_assertion description "[These data provide evidence that pEGFR expression is related to angiogenesis (via VEGFR-1/Flt-1, MMP-14 and pAkt pathways) and invasiveness (via uPAR, MMP-14 and pAkt pathways) and that the EGFR/pEGFR phenotype is associated with poor patient survival in invasive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP566413.RAPv7IUCcEE0H9LuU2HC04amGNdtKWkLwtWMK4waykx0w130_provenance.
• NP370181.RAGSinpkKdVFYlxJfTA1SEuDSZwATukGvpm_hR41W2vMg130_assertion description "[These data provide evidence that pEGFR expression is related to angiogenesis (via VEGFR-1/Flt-1, MMP-14 and pAkt pathways) and invasiveness (via uPAR, MMP-14 and pAkt pathways) and that the EGFR/pEGFR phenotype is associated with poor patient survival in invasive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP370181.RAGSinpkKdVFYlxJfTA1SEuDSZwATukGvpm_hR41W2vMg130_provenance.
• NP407733.RAG1aKlfQfoG66vtGLnEeCxzfo3wanzu3OqxsZE5lbvpE130_assertion description "[These data provide evidence that pEGFR expression is related to angiogenesis (via VEGFR-1/Flt-1, MMP-14 and pAkt pathways) and invasiveness (via uPAR, MMP-14 and pAkt pathways) and that the EGFR/pEGFR phenotype is associated with poor patient survival in invasive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP407733.RAG1aKlfQfoG66vtGLnEeCxzfo3wanzu3OqxsZE5lbvpE130_provenance.
• NP674825.RAM-wXsfXSNZFacXJJakjCsULoIz1cgi_WY5_U9oBsULo130_assertion description "[These data provide evidence that pEGFR expression is related to angiogenesis (via VEGFR-1/Flt-1, MMP-14 and pAkt pathways) and invasiveness (via uPAR, MMP-14 and pAkt pathways) and that the EGFR/pEGFR phenotype is associated with poor patient survival in invasive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP674825.RAM-wXsfXSNZFacXJJakjCsULoIz1cgi_WY5_U9oBsULo130_provenance.
• NP674826.RA_ZqIrYePuqpGhenhuGx-olPQD8R0_qYSPSqf6iXNjPc130_assertion description "[These data provide evidence that pEGFR expression is related to angiogenesis (via VEGFR-1/Flt-1, MMP-14 and pAkt pathways) and invasiveness (via uPAR, MMP-14 and pAkt pathways) and that the EGFR/pEGFR phenotype is associated with poor patient survival in invasive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP674826.RA_ZqIrYePuqpGhenhuGx-olPQD8R0_qYSPSqf6iXNjPc130_provenance.